Lv51
820 积分 2022-01-04 加入
T-cell Engagers in Prostate Cancer
2小时前
待确认
Perils and Problems in Bispecific T-Cell Engager Antibodies
2小时前
待确认
IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer
6小时前
待确认
Phage Display: A Laboratory Manual. Edited by C. F. Barbas III, D. R. Burton, J. K. Scott, and G. J. Silverman
5天前
已完结
Targeting Solid Tumors Using CD3 Bispecific Antibodies
7天前
已完结
Looking ahead to CD3, T-cell engager bispecific antibodies for hematological malignancies
7天前
已完结
Back on the scene: Advances and challenges in CD3-related drugs in tumor therapy
7天前
已完结
T-cell-engaging bispecific antibodies in cancer
9天前
已完结
PIT565, a First-in-Class Anti-CD19, Anti-CD3, Anti-CD2 Trispecific Antibody for the Treatment of B Cell Malignancies
12天前
已完结
Back on the scene: Advances and challenges in CD3-related drugs in tumor therapy
18天前
已完结
皖公网安备34019202002308
